Barton Publishing review: Question the purpose of slamming the effects of Metformin

As a Nurse Practitioner, PhD, and Certified Diabetes Care and Education Specialist with 30 years of diabetes-focused practice, I find it difficult to take at face value claims that metformin unequivocally weakens muscles. The video lacks any scientifically based references and seems bent on stating as fact the mixed findings of referenced journals.
A recent article reporting on the metformin - muscle loss relationship concluded: "The question of whether metformin causes muscle loss is best answered with a balanced, context-aware perspective. While mechanistic and clinical trial data indicate that metformin can blunt muscle hypertrophy in older adults undertaking resistance training, its effects are not universally detrimental. In fact, other evidence suggests metformin can protect against disuse-induced atrophy and may even help mitigate age-related muscle decline (sarcopenia) through its anti-inflammatory and anti-senescence properties.

For most patients, metformin's metabolic benefits—improved insulin sensitivity and reduced risk of diabetes complications—far outweigh concerns about muscle mass, especially since exercise remains highly beneficial. The key is to manage expectations, especially for those pursuing resistance training, and to monitor for any unusual muscle pain or weakness that could signal a rare complication like lactic acidosis. Regular communication with a healthcare provider is essential for optimizing the benefits of metformin while minimizing risks, especially regarding exercise and potential side effects.

There is growing evidence that metformin has anti-cancer effects based on clinical and preclinical studies. A meta-analysis conducted on 17 studies observed a significant reduction in cancer risk with the use of metformin in patients with diabetes or without diabetes, as compared to patients not on metformin (Soranna D, Scotti L, Zambon A, et al. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist. 2012;17(6):813–822).
Jonathan Petrocelli, Ph.D., from the University of Utah shared research findings that metformin helps muscle cells better remodel and repair tissue during periods of recovery after inactivity. (Petrocelli, J. J., et al.,(2023). Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment. Aging Cell, 22(11), e13936.